Compare QDEL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QDEL | INMD |
|---|---|---|
| Founded | 1979 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 842.0M |
| IPO Year | 2022 | 2018 |
| Metric | QDEL | INMD |
|---|---|---|
| Price | $14.12 | $13.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $28.25 | $17.33 |
| AVG Volume (30 Days) | ★ 1.7M | 689.4K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.35 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,730,200,000.00 | N/A |
| Revenue This Year | $3.51 | $1.74 |
| Revenue Next Year | $3.86 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.92 | $12.72 |
| 52 Week High | $35.58 | $16.74 |
| Indicator | QDEL | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 41.90 |
| Support Level | $10.39 | $13.29 |
| Resistance Level | $15.76 | $13.87 |
| Average True Range (ATR) | 1.05 | 0.22 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 62.77 | 17.67 |
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.